CBD, itself or in synergy with bortezomib, is able to inhibit growth, arrest cell cycle progression, and induce MM cell death by regulating the ERK, Akt, and NF-κB pathways with major effects in CD138+TRPV2+ MM cells [86,87]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.